Annual report pursuant to Section 13 and 15(d)

Revenues from Contracts and Significant Customers (Narrative) (Details)

v3.22.1
Revenues from Contracts and Significant Customers (Narrative) (Details)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dermatology Products Sales [Member] | One Customer [Member] | Customer Concentration Risk [Member] | Accounts Receivable [Member]    
Disaggregation of Revenue [Line Items]    
Concentration risk, percentage 12.00% 12.00%